Why the study?
Does primary prevention by multiple risk factor modification reduce mortality from coronary heart disease and the incidence of coronary events in high-risk populations?
Does primary prevention by multiple risk factor modification reduce mortality from coronary heart disease and the incidence of coronary events in high-risk populations?
Primary prevention through multiple risk factor modification (smoking cessation, cholesterol reduction, and hypertension treatment) contributes to the observed decline in coronary heart disease mortality.
Supports multiple risk factor modification in primary prevention; confirms observational links but leaves open need for contemporary RCTs.
Many factors have probably contributed to the observed decline in mortality from coronary disease in the United States since 1968. The issue of whether the incidence of such disease is declining remains to be clarified. The efficacy of primary prevention of coronary artery disease by multiple risk factor modification has been tested in large-scale clinical trials. Among middle-aged, normotensive, hypercholesterolemic smokers, smoking cessation and reduction of cholesterol levels by dietary change are followed by a decreased incidence of coronary events. Groups at high risk because of the combination of hypertension, cigarette smoking, and hypercholesterolemia show reduced coronary disease mortality after drug treatment of hypertension combined with cessation or reduction of cigarette smoking and dietary reduction of cholesterol levels. Primary prevention may be more effective if efforts begin early in life before behaviors and physiologic characteristics that may increase risk become established.
No takes yet. Share an insight, caveat, or question.
Laurence O. Watkins (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: